Compile Data Set for Download or QSAR
Report error Found 34 Enz. Inhib. hit(s) with all data for entry = 50020711
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632958(CHEMBL5435382)
Affinity DataIC50: 7nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632959(CHEMBL5417464)
Affinity DataIC50: 36nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50201567(CHEMBL3901198)
Affinity DataKi:  70nMAssay Description:Binding affinity to human C1S assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632957(CHEMBL5418327)
Affinity DataIC50: 170nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50201567(CHEMBL3901198)
Affinity DataKi:  180nMAssay Description:Binding affinity to trypsin (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632952(CHEMBL5407328)
Affinity DataIC50: 370nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632953(CHEMBL5410431)
Affinity DataIC50: 390nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632950(CHEMBL5418278)
Affinity DataIC50: 560nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632946(CHEMBL5437582)
Affinity DataIC50: 580nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632956(CHEMBL5432292)
Affinity DataIC50: 820nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632949(CHEMBL5398476)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632954(CHEMBL5437882)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632955(CHEMBL5439103)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632943(CHEMBL5411534)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement factor D(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50201567(CHEMBL3901198)
Affinity DataKi:  3.70E+3nMAssay Description:Binding affinity to factor D (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632947(CHEMBL5398549)
Affinity DataIC50: 4.20E+3nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632945(CHEMBL5411177)
Affinity DataIC50: 5.10E+3nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632951(CHEMBL5412594)
Affinity DataIC50: 6.70E+3nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetProthrombin(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632959(CHEMBL5417464)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human thrombin using L5-FAM/QXLTM 520 thrombin as substrate pretreated with compound followed by substrate addition incubated for 60 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632961(CHEMBL5431053)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human recombinant trypsin using Boc-phe-Ser-Arg-MCA as substrate pretreated with compound followed by substrate addition incubated for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement factor D(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632959(CHEMBL5417464)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged factor D (26 to 253 aa residues) expressed in Expi293 cells using Z-L...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetProthrombin(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632961(CHEMBL5431053)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human thrombin using L5-FAM/QXLTM 520 thrombin as substrate pretreated with compound followed by substrate addition incubated for 60 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632959(CHEMBL5417464)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human recombinant trypsin using Boc-phe-Ser-Arg-MCA as substrate pretreated with compound followed by substrate addition incubated for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlasminogen(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632959(CHEMBL5417464)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human recombinant plasmin using Boc-Val-Leu-Lys-MCA as substrate pretreated with compound followed by substrate addition incubated for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1r subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632961(CHEMBL5431053)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1R (375 to 705 aa residues) expressed in HEK293 cells using Z-Gly-Ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632948(CHEMBL5424714)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetMannan-binding lectin serine protease 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632959(CHEMBL5417464)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged MASP2 (298 to 686 aa residues) expressed in Expi293 cells using Z-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement factor D(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632961(CHEMBL5431053)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged factor D (26 to 253 aa residues) expressed in Expi293 cells using Z-L...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1r subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632959(CHEMBL5417464)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1R (375 to 705 aa residues) expressed in HEK293 cells using Z-Gly-Ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetMannan-binding lectin serine protease 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632961(CHEMBL5431053)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged MASP2 (298 to 686 aa residues) expressed in Expi293 cells using Z-Gly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetProthrombin(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50201567(CHEMBL3901198)
Affinity DataKi: >5.00E+4nMAssay Description:Binding affinity to thrombin (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632942(CHEMBL5410965)
Affinity DataIC50: 9.60E+4nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632944(CHEMBL5413734)
Affinity DataIC50: 3.00E+5nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetComplement C1s subcomponent(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50632960(CHEMBL5418024)
Affinity DataIC50: 3.00E+5nMAssay Description:Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged C1S (358 to 688 aa residues) expressed in HEK293 cells using Z-Lys-SB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed